Abstract

BackgroundIncreased permeability of the intestinal wall and intestinal dysbiosis may contribute to chronic systemic inflammation, one of the causes of accelerated atherosclerosis and cardiovascular morbidity and mortality burden in patients with chronic kidney disease. The aim of this study was to evaluate the association between markers of intestinal permeability and inflammation in haemodialysis (HD) patients.MethodsPlasma concentration of zonulin, haptoglobin, TNFα, IL6, d-lactates and bacterial lipopolysaccharides (LPS) was assessed in blood samples obtained after overnight fast before midweek morning HD session in 150 stable, prevalent HD patients. Daily intake of energy and macronutrients was assessed on the basis of a food frequency questionnaire.ResultsSerum hsCRP level was increased in over 70% of patients. Plasma levels of zonulin [11.6 (10.9–12.3) vs 6.8 (5.8–7.8) ng/mL], IL6 [6.2 (1.0–10.3) vs 1.3 (1.0–2.0) pg/mL] and TNFα [5.9 (2.9–11.8) vs 1.6 (1.3–1.8) pg/mL], but not LPS and d-lactates were significantly higher in HD than in healthy controls. d-lactates and LPS levels were weakly associated with IL6 (R = 0.175; p = 0.03, and R = 0.241; p = 0.003). There was a borderline correlation between plasma zonulin and serum hsCRP (R = 0.159; p = 0.07), but not with IL6, LPS and d-lactates. In multiple regression, both serum CRP and plasma IL6 variability were explained by LPS (β = 0.143; p = 0.08 and β = 0.171; p = 0.04, respectively), only.ConclusionThe weak association between plasma d-lactate, LPS and IL6 levels indicates that intestinal flora overgrowth or increased intestinal permeability contributes very slightly to the chronic inflammation development in HD patients.

Highlights

  • The accelerated development of atherosclerosis is one of the main causes of precocious cardiovascular morbidity and mortality in dialysis patients with chronic kidney disease (CKD) [1]. It can be explained by the co-occurrence of classic cardiovascular risk factors and the so-called uraemia-specific risk factors, which include CKD-MBD, oxidative stress, accumulation of advanced glycation end products (AGEs), uraemic retention solutes (e.g. guanidine, asymmetric dimethylarginine (ADMA), p-cresol, indoxyl sulphate), as well as low-grade chronic systemic inflammation [2,3,4,5]

  • One hundred and fifty haemodialysis patients were included in the study

  • The levels of zonulin, hsCRP, IL6 and TNFα were significantly higher in HD patients, while the levels of haptoglobin, LPS and d-lactates were similar in both study groups

Read more

Summary

Introduction

The accelerated development of atherosclerosis is one of the main causes of precocious cardiovascular morbidity and mortality in dialysis patients with chronic kidney disease (CKD) [1]. It can be explained by the co-occurrence of classic cardiovascular risk factors (age, sex, hypertension, lipid disorders, diabetes or obesity) and the so-called uraemia-specific risk factors, which include CKD-MBD (chronic kidney disease—mineral and bone disorders), oxidative stress, accumulation of advanced glycation end products (AGEs), uraemic retention solutes (e.g. guanidine, asymmetric dimethylarginine (ADMA), p-cresol, indoxyl sulphate), as well as low-grade chronic systemic inflammation (microinflammation) [2,3,4,5]. Increased permeability of the intestinal wall and intestinal dysbiosis may contribute to chronic systemic inflammation, one of the causes of accelerated atherosclerosis and cardiovascular morbidity and mortality burden in patients with chronic kidney disease. The aim of this study was to evaluate the association between markers of intestinal permeability and inflammation in haemodialysis (HD) patients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call